Literature DB >> 26514634

R/S Ratio Variability in Lead V1 Observed between Selected Four 1-Minute ECG Fragments of 24-Hour ECG as a Predictor of Incomplete Resynchronization during Full 24-Hour ECG: Pilot Study.

Dominika Pyszno-Prokopowicz1, Rafał Baranowski2, Robert Bodalski2, Magdalena Madej2, Ryszard Piotrowicz1.   

Abstract

BACKGROUND: About 30% of patients do not have an effective cardiac resynchronization therapy (CRT). Routine assessment of CRT by devices interrogation (DI) is not entirely reliable. Additional information provide detailed QRS analysis in 24-hour ECG, however it is time-consuming. The aim of the study was the assessment of R/S ratio variability in lead V1 between selected fragments of 24-hour ECG as a predictor of incomplete biventricular pacing (BIVP) during full 24-hour ECG.
METHODS: The 12-lead 24-hour ECGs of 43 patients with sinus rhythm were studied. During 24-hour ECG the 6-minute walk test (6MWT) was performed. The CRT was assessed by analyzing DI and full 24-hour ECG and four 1-minute fragments of these ECG recordings: during the minimum and the maximum heart rate and at the 1st and last minute of 6MWT.
RESULTS: During DI the effective (>95%) BIVP was present in 36 patients (83.7%). Analysis of full 24-hour ECG confirmed appropriate BIVP in 31 patients (72%) and suspected incomplete BIVP (≤95%) in 12 patients (28%). In 9/12 patients the R/S ratio variability in lead V1 was visible between selected ECG fragments of 24-hour ECG. These results were not associated with the results of DI but were significantly associated with full 24-hour analysis of QRS.
CONCLUSIONS: R/S variability in lead V1 between selected fragments of 24-hour ECG can be considered a predictor of potentially incomplete BIVP confirmed by further complete 24-hour ECG analysis in patients with appropriate pacing reported during DI.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  24-hour ECG; 6-minute walk test; cardiac resynchronization pacing; the QRS-variability

Mesh:

Year:  2015        PMID: 26514634      PMCID: PMC6931509          DOI: 10.1111/anec.12326

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  8 in total

1.  [The 6-minute walking test--clinical usefulness and limitations].

Authors:  Jadwiga Wolszakiewicz
Journal:  Kardiol Pol       Date:  2010-02       Impact factor: 3.108

2.  Desperately seeking a randomized clinical trial of resynchronization therapy for patients with heart failure and atrial fibrillation.

Authors:  Jonathan S Steinberg
Journal:  J Am Coll Cardiol       Date:  2006-07-24       Impact factor: 24.094

3.  Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association.

Authors:  Panos E Vardas; Angelo Auricchio; Jean-Jacques Blanc; Jean-Claude Daubert; Helmut Drexler; Hugo Ector; Maurizio Gasparini; Cecilia Linde; Francisco Bello Morgado; Ali Oto; Richard Sutton; Maria Trusz-Gluza
Journal:  Eur Heart J       Date:  2007-08-28       Impact factor: 29.983

4.  Analysis of the QRS morphology in lead V1 during 24-hour Holter electrocardiogram monitoring to evaluate function of a cardiac resynchronisation therapy device in patients with sinus rhythm: a pilot study.

Authors:  Dominika Pyszno-Prokopowicz; Magdalena Madej; Rafał Baranowski; Ryszard Piotrowicz
Journal:  Kardiol Pol       Date:  2015-01-07       Impact factor: 3.108

5.  Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation.

Authors:  Maurizio Gasparini; Angelo Auricchio; François Regoli; Cecilia Fantoni; Mihoko Kawabata; Paola Galimberti; Daniela Pini; Carlo Ceriotti; Edoardo Gronda; Catherine Klersy; Simona Fratini; Helmut H Klein
Journal:  J Am Coll Cardiol       Date:  2006-07-24       Impact factor: 24.094

6.  The utility of 12-lead Holter monitoring in patients with permanent atrial fibrillation for the identification of nonresponders after cardiac resynchronization therapy.

Authors:  Ganesh S Kamath; Delia Cotiga; Jayanthi N Koneru; Aysha Arshad; Walter Pierce; Emad F Aziz; Anisha Mandava; Suneet Mittal; Jonathan S Steinberg
Journal:  J Am Coll Cardiol       Date:  2009-03-24       Impact factor: 24.094

Review 7.  Cardiac resynchronization therapy and atrial fibrillation.

Authors:  Ganesh S Kamath; Jonathan S Steinberg
Journal:  Cardiol J       Date:  2009       Impact factor: 2.737

Review 8.  Cardiac resynchronization therapy in heart failure patients with atrial fibrillation.

Authors:  Maurizio Gasparini; François Regoli; Paola Galimberti; Carlo Ceriotti; Alessio Cappelleri
Journal:  Europace       Date:  2009-11       Impact factor: 5.214

  8 in total
  1 in total

1.  2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry.

Authors:  Jonathan S Steinberg; Niraj Varma; Iwona Cygankiewicz; Peter Aziz; Paweł Balsam; Adrian Baranchuk; Daniel J Cantillon; Polychronis Dilaveris; Sergio J Dubner; Nabil El-Sherif; Jaroslaw Krol; Malgorzata Kurpesa; Maria Teresa La Rovere; Suave S Lobodzinski; Emanuela T Locati; Suneet Mittal; Brian Olshansky; Ewa Piotrowicz; Leslie Saxon; Peter H Stone; Larisa Tereshchenko; Mintu P Turakhia; Gioia Turitto; Neil J Wimmer; Richard L Verrier; Wojciech Zareba; Ryszard Piotrowicz
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-05       Impact factor: 1.468

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.